Nu Skin Enterprises (NYSE:NUS – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 8th. Analysts expect Nu Skin Enterprises to post earnings of $0.05 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last issued its quarterly earnings data on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.08. Nu Skin Enterprises had a net margin of 0.44% and a return on equity of 10.73%. The company had revenue of $488.64 million during the quarter, compared to the consensus estimate of $479.35 million. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Nu Skin Enterprises Stock Down 1.7 %
Shares of NUS stock opened at $12.20 on Tuesday. The firm has a fifty day moving average of $12.66 and a 200-day moving average of $15.97. The company has a quick ratio of 1.28, a current ratio of 2.13 and a debt-to-equity ratio of 0.58. Nu Skin Enterprises has a 12-month low of $11.73 and a 12-month high of $39.12. The company has a market capitalization of $602.94 million, a price-to-earnings ratio of 67.78 and a beta of 1.13.
Nu Skin Enterprises Cuts Dividend
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $23.67.
View Our Latest Stock Analysis on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
- Five stocks we like better than Nu Skin Enterprises
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Value Stocks You Can Buy Before They Become Big
- Profitably Trade Stocks at 52-Week Highs
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.